Controlled direct effects of preeclampsia on neonatal health after accounting for mediation by preterm birth

Epidemiology

Volumn 26, Issue 1, 2015, Pages 17-26

  Mendola, Pauline ^a   Mumford, Sunni L ^a   Männistö, Tuija I ^a,b   Holston, Alexander ^c   Reddy, Uma M ^a   Katherine Laughon, S ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c Naval Medical Center Portsmouth   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN HEMORRHAGE; CARDIOMYOPATHY; CESAREAN SECTION; CHORIOAMNIONITIS; CONTROLLED STUDY; ECLAMPSIA; FEMALE; FETUS MALFORMATION; GENITAL HERPES; GESTATIONAL AGE; HUMAN; HYDRAMNIOS; MACROSOMIA; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL HYPERTENSION; NEONATAL INTENSIVE CARE UNIT; NEWBORN; NEWBORN ANEMIA; NEWBORN APNEA; NEWBORN DISEASE; NEWBORN HYPOXIA; NEWBORN MORBIDITY; PERINATAL MORTALITY; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SMALL FOR DATE INFANT; TRANSIENT TACHYPNEA OF THE NEWBORN; ASPHYXIA NEONATORUM; CEREBRAL HEMORRHAGE; MALE; NEWBORN INTENSIVE CARE; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK FACTOR; TERM BIRTH; UNITED STATES; UTILIZATION; YOUNG ADULT;

ADULT; ASPHYXIA NEONATORUM; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; PERINATAL MORTALITY; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK FACTORS; TERM BIRTH; TRANSIENT TACHYPNEA OF THE NEWBORN; UNITED STATES; YOUNG ADULT;

EID: 84937561777     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000213     Document Type: Article

References (35)

1. L indheimer MD, Taler SJ, Cunningham FG. ASH position paper: hypertension in pregnancy. J Clin Hypertens (Greenwich). 2009;11:214-225.
2. L evine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683.
3. L evine RJ, Lam C, Qian C et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355: 992-1005.
4. Wang A, Holston AM, Yu KF, et al. Circulating anti-Angiogenic factors during hypertensive pregnancy and increased risk of respiratory distress syndrome in preterm neonates. J Matern Fetal Neonatal Med. 2012;25:1447-1452.
5. Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011;31:33-46.
6. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785-799.
7. A uger N, Le TU, Park AL, Luo ZC. Association between maternal comorbidity and preterm birth by severity and clinical subtype: retrospective cohort study. BMC Preg Childbirth. 2011;11:67.
8. Yu XD, Branch DW, Karumanchi SA, Zhang J. Preeclampsia and retinopathy of prematurity in preterm births. Pediatrics. 2012;130:e101-e107.
9. Fortes Filho JB, Costa MC, Eckert GU, Santos PG, Silveira RC, Procianoy RS. Maternal preeclampsia protects preterm infants against severe retinopathy of prematurity. J Pediatr. 2011;158:372-376.
10. VanderWeele TJ, Mumford SL, Schisterman EF. Conditioning on intermediates in perinatal epidemiology. Epidemiology. 2012;23:1-9.
11. Strand KM, Heimstad R, Iversen AC , et al. Mediators of the association between pre-eclampsia and cerebral palsy: population based cohort study. BMJ. 2013;347:f4089.
12. Mann JR, McDermott S, Griffith MI, Hardin J, Gregg A. Uncovering the complex relationship between pre-eclampsia, preterm birth and cerebral palsy. Paediatr Perinat Epidemiol. 2011;25:100-110.
13. T rønnes H, Wilcox AJ, Lie RT , Markestad T, Moster D. Risk of cerebral palsy in relation to pregnancy disorders and preterm birth: A national cohort study. Dev Med Child Neurol. 2014;56:779-785.
14. VanderWeele TJ, Hernández-Diaz S. Is there a direct effect of pre-eclampsia on cerebral palsy not through preterm birth? Paediatr Perinat Epidemiol. 2011;25:111-115.
15. VanderWeele TJ. Marginal structural models for the estimation of direct and indirect effects. Epidemiology. 2009;20:18-26.
16. Zhang J, Troendle J, Reddy UM et al. Contemporary cesarean delivery practice in the United States. Am J Obstet Gynecol. 2010;203:326.
17. Männistö T, Mendola P, Reddy U, Laughon SK. Neonatal outcomes and birth weight in pregnancies complicated by maternal thyroid disease. Am J Epidemiol. 2013;178:731-740.
18. R obins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550-560.
19. R obins JM, Greenland S. Identifiability and exchangeability for direct and indirect effects. Epidemiology. 1992;3:143-155.
20. C ole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168:656-664.
21. VanderWeele TJ. Bias formulas for sensitivity analysis for direct and indirect effects. Epidemiology. 2010;21:540-551.
22. MacLehose RF, Kaufman JS. Commentary: The wizard of odds. Epidemiology 2012;23:10-12.
23. R aymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66:497-506.
24. VanderWeele TJ. A three-way decomposition of a total effect into direct, indirect, and interactive effects. Epidemiology. 2013;24:224-232.
25. Moore AG , Young H, Keller JM, et al. Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia. J Matern Fetal Neonatal Med. 2012;25:2651-2657.
26. Habli M, Levine RJ, Qian C, Sibai B. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Am J Obstet Gynecol. 2007;197:406.e1-7.
27. Wang CN, Chang SD, Peng HH, et al. Change in amniotic fluid levels of multiple anti-Angiogenic proteins before development of preeclampsia and intrauterine growth restriction. J Clin Endocrinol Metab. 2010;95:1431-1441.
28. Staff AC , Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2005;122:33-39.
29. Park CW, Park JS, Shim SS, Jun JK, Yoon BH, Romero R. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-Trimester genetic amniocentesis is a risk factor for preeclampsia. Am J Obstet Gynecol. 2005;193(3 Pt 2):984-989.
30. Kalay S, Cakcak B, Oztekin O, et al. The role of VEGF and its soluble receptor VEGFR-1 in preterm newborns of preeclamptic mothers with RDS. J Matern Fetal Neonatal Med. 2013;26:978-983.
31. A ncel PY, Marret S, Larroque B, et al. Are maternal hypertension and small-for-gestational age risk factors for severe intraventricular hemorrhage and cystic periventricular leukomalacia? Results of the EPIPAGE cohort study. Am J Obstet Gynecol. 2005;193:178-184.
32. McElrath TF, Allred EN, Boggess KA, et al. Maternal antenatal complications and the risk of neonatal cerebral white matter damage and later cerebral palsy in children born at an extremely low gestational age. Am J Epidemiol. 2009;170:819-828.
33. Kaufman JS, Maclehose RF, Kaufman S. A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation. Epidemiol Perspect Innov. 2004;1:4.
34. Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol. 2011;205:191-198.
35. Sibai BM. Management of late preterm and early-Term pregnancies complicated by mild gestational hypertension/pre-eclampsia. Semin Perinatol. 2011;35:292-296.